Moody Aldrich Partners’s CRISPR Therapeutics CRSP Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-28,733	Closed	-$1.88M	–	161
2022 Q3	$1.88M	Buy	+28,733	New	+$1.88M	0.39%	84
2019 Q3	–	Sell	-39,017	Closed	-$1.84M	–	128
2019 Q2	$1.84M	Buy	+39,017	New	+$1.84M	0.47%	80